• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病及其隐匿伴发症:高胰岛素血症及其并发症的批判性综述

Diabetes and its Silent Partner: A Critical Review of Hyperinsulinemia and its Complications.

作者信息

Rangraze Imran Rashid, El-Tanani Mohamed, Arman Rabbani Syed, Babiker Rasha, Matalka Ismail I, Rizzo Manfredi

机构信息

Internal Medicine Department, RAK College of Medical Sciences, RAK Medical and Health Sciences University, Rasal- Khaimah, United Arab Emirates.

College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.

出版信息

Curr Diabetes Rev. 2025;21(9):e15733998311738. doi: 10.2174/0115733998311738240813110032.

DOI:10.2174/0115733998311738240813110032
PMID:39192649
Abstract

In this complex realm of diabetes, hyperinsulinemia is no longer regarded as just a compensatory response to insulin resistance but rather has evolved into an integral feature. This comprehensive review provides a synthesis of the current literature, including various aspects associated with hyperinsulinemia in diabetic complications. Hyperinsulinemia has been shown to be more than just a compensatory mechanism, and the key findings demonstrate how hyperinsulinism affects the development of cardiovascular events as well as microvascular complications. Additionally, recognizing hyperinsulinemia as a modifiable factor, the diabetes management paradigm shifts towards cognitive ones that consider the use of lifestyle modifications in combination with newer pharmacotherapies and precision medicine approaches. These findings have crucial implications for the clinical work, requiring a careful appreciation of hyperinsulinemia's changing aspects as well as incorporation in personalized treatment protocol. In addition, the review focuses on bigger issues related to public health, showing that prevention and early diagnosis will help reduce the burden of complications. Research implications favor longitudinal studies, biomarker discovery, and the study of emerging treatment modalities; clinical practice should adopt global evaluations, patient education, and precision medicine adaptation. Finally, this critical review provides an overview of the underlying processes of hyperinsulinemia in diabetes and its overall health effects.

摘要

在糖尿病这个复杂领域,高胰岛素血症不再仅仅被视为对胰岛素抵抗的一种代偿反应,而是已演变成一个不可或缺的特征。这篇全面综述对当前文献进行了综合,涵盖了与糖尿病并发症中高胰岛素血症相关的各个方面。高胰岛素血症已被证明不仅仅是一种代偿机制,关键研究结果表明高胰岛素血症如何影响心血管事件以及微血管并发症的发生发展。此外,认识到高胰岛素血症是一个可调节因素后,糖尿病管理模式转向认知模式,即考虑结合生活方式改变、新型药物疗法和精准医学方法。这些发现对临床工作具有至关重要的意义,需要仔细认识高胰岛素血症不断变化的方面,并将其纳入个性化治疗方案。此外,该综述关注与公共卫生相关的更大问题,表明预防和早期诊断将有助于减轻并发症负担。研究意义在于支持纵向研究、生物标志物发现以及新兴治疗模式的研究;临床实践应采用全面评估、患者教育和精准医学应用。最后,这篇批判性综述概述了糖尿病中高胰岛素血症的潜在机制及其对整体健康的影响。

相似文献

1
Diabetes and its Silent Partner: A Critical Review of Hyperinsulinemia and its Complications.糖尿病及其隐匿伴发症:高胰岛素血症及其并发症的批判性综述
Curr Diabetes Rev. 2025;21(9):e15733998311738. doi: 10.2174/0115733998311738240813110032.
2
Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer.高胰岛素血症及其在衰老、肥胖、2 型糖尿病、心血管疾病和癌症中的关键作用。
Int J Mol Sci. 2021 Jul 21;22(15):7797. doi: 10.3390/ijms22157797.
3
[Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data].[高胰岛素血症在大血管病变中的致病作用。流行病学数据]
Presse Med. 1992 Sep 9;21(28):1307-11.
4
Hyperinsulinemia in Obesity, Inflammation, and Cancer.肥胖、炎症和癌症中的高胰岛素血症。
Diabetes Metab J. 2021 May;45(3):285-311. doi: 10.4093/dmj.2020.0250. Epub 2021 Mar 29.
5
Effects of chronic hyperinsulinemia in insulin-resistant patients.慢性高胰岛素血症对胰岛素抵抗患者的影响。
Curr Diab Rep. 2008 Jun;8(3):233-8. doi: 10.1007/s11892-008-0040-z.
6
Hyperandrogenism, insulin resistance and hyperinsulinemia as cardiovascular risk factors in diabetes mellitus.高雄激素血症、胰岛素抵抗和高胰岛素血症作为糖尿病的心血管危险因素。
Curr Diabetes Rev. 2006 Feb;2(1):39-49. doi: 10.2174/157339906775473635.
7
[Diabetes and cancer risk: oncologic considerations].[糖尿病与癌症风险:肿瘤学考量]
Orv Hetil. 2011 Jul 17;152(29):1144-55. doi: 10.1556/OH.2011.29158.
8
Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy's safety profile.消除2型糖尿病患者对胰岛素治疗的大部分需求:对胰岛素治疗安全性的重新评估。
Postgrad Med. 2016 Aug;128(6):609-19. doi: 10.1080/00325481.2016.1191955. Epub 2016 Jun 3.
9
Diabetes and cancer: a 2013 synopsis.糖尿病与癌症:2013年综述
Diabetes Metab Syndr. 2013 Oct-Dec;7(4):247-50. doi: 10.1016/j.dsx.2013.08.001. Epub 2013 Sep 12.
10
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.胰岛素抵抗、胰岛素抵抗综合征与心血管疾病。
Panminerva Med. 2005 Dec;47(4):201-10.

引用本文的文献

1
Cognitive disorders in diabetes.糖尿病中的认知障碍。
Front Clin Diabetes Healthc. 2025 Feb 24;6:1534105. doi: 10.3389/fcdhc.2025.1534105. eCollection 2025.

本文引用的文献

1
A high-fat and fructose diet in dogs mirrors insulin resistance and β-cell dysfunction characteristic of impaired glucose tolerance in humans.高脂肪果糖饮食会使犬产生类似于人类葡萄糖耐量受损时的胰岛素抵抗和β细胞功能障碍。
PLoS One. 2023 Dec 22;18(12):e0296400. doi: 10.1371/journal.pone.0296400. eCollection 2023.
2
Lifestyle Therapy Targeting Hyperinsulinemia Normalizes Hyperglycemia and Surrogate Markers of Insulin Resistance in a Large, Free-Living Population.针对高胰岛素血症的生活方式疗法可使大量自由生活人群的高血糖和胰岛素抵抗替代指标恢复正常。
AJPM Focus. 2022 Sep 16;1(2):100034. doi: 10.1016/j.focus.2022.100034. eCollection 2022 Dec.
3
Advances in the Management of Diabetes Mellitus: A Focus on Personalized Medicine.
糖尿病管理的进展:聚焦个性化医疗。
Cureus. 2023 Aug 18;15(8):e43697. doi: 10.7759/cureus.43697. eCollection 2023 Aug.
4
Insulin and the kidneys: a contemporary view on the molecular basis.胰岛素与肾脏:分子基础的当代观点
Front Nephrol. 2023 Aug 3;3:1133352. doi: 10.3389/fneph.2023.1133352. eCollection 2023.
5
Vascular nitric oxide resistance in type 2 diabetes.2 型糖尿病中的血管一氧化氮抵抗。
Cell Death Dis. 2023 Jul 11;14(7):410. doi: 10.1038/s41419-023-05935-5.
6
Signaling pathways and intervention for therapy of type 2 diabetes mellitus.2型糖尿病治疗的信号通路与干预措施
MedComm (2020). 2023 Jun 7;4(3):e283. doi: 10.1002/mco2.283. eCollection 2023 Jun.
7
Identification of biomarkers for glycaemic deterioration in type 2 diabetes.识别 2 型糖尿病患者血糖恶化的生物标志物。
Nat Commun. 2023 May 3;14(1):2533. doi: 10.1038/s41467-023-38148-7.
8
Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes.非酒精性脂肪性肝病中降低肝脏脂肪的治疗潜力:与2型糖尿病密切相关
Metabolites. 2023 Apr 4;13(4):517. doi: 10.3390/metabo13040517.
9
The crucial role and mechanism of insulin resistance in metabolic disease.胰岛素抵抗在代谢性疾病中的关键作用及其机制。
Front Endocrinol (Lausanne). 2023 Mar 28;14:1149239. doi: 10.3389/fendo.2023.1149239. eCollection 2023.
10
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies.糖尿病血管病变:分子机制与治疗策略。
Signal Transduct Target Ther. 2023 Apr 10;8(1):152. doi: 10.1038/s41392-023-01400-z.